Sara M Schuster, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1001 E Johnson St, Holyoke, CO 80734 Phone: 970-854-2241 Fax: 970-458-4581 |
News Archive
"A malaria drug made by India's Cipla has been pre-qualified by the World Health Organization (WHO), an important step towards its roll-out across Asia, where millions of people are infected with the mosquito-borne disease every year," Reuters reports.
A coalition of more than 150 humanitarian groups expressed "concern" in a letter Thursday that more than half of the U.S. government's disaster-assistance program budget has been pledged to help Haiti, which they say could mean cuts for aid to countries such as Sudan or Somalia, the Washington Post reports.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces today further positive results from the phase 2b PILLAR study of TMC435 in treatment-naive patients with hepatitis C virus genotype-1.
Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.
› Verified 2 days ago